Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: Medpace | History Defined

6 Healthcare Stocks With Strong Upward Momentum

Out with the old (tech), in with the new (healthcare). After several volatile weeks, it appears a full-fledged rotation has begun with investors fleeing previously high-flying tech winners in favor of underserved healthcare stocks.

Medpace Analysts Increase Their Forecasts After Upbeat Q3 Earnings

Medpace Analysts Increase Their Forecasts After Upbeat Q3 Earnings

Medpace Holdings Inc. (NASDAQ:MEDP) posted better-than-expected third-quarter earnings on Thursday.

Medpace's Q3 Earnings Beat Reflects Robust Growth And Large New Wins

Medpace's Q3 Earnings Beat Reflects Robust Growth And Large New Wins

Medpace Holdings Inc. (NASDAQ:MEDP) is trading higher on Thursday after the company released third-quarter earnings.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Medspace Stock Is Trading Higher Tuesday: What's Going On?

Medpsace Holdings, Inc. (NASDAQ:MEDP) shares are trading higher Tuesday. The company reported second-quarter earnings on Monday after the market closed.

Top 2 Health Care Stocks You May Want To Dump This Quarter

As of July 22, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Why Medpace Shares Are Trading Higher By 45%; Here Are 20 Stocks Moving Premarket

Shares of Medpace Holdings, Inc. (NASDAQ:MEDP) rose sharply in pre-market trading after the company reported strong financial results for the second quarter and raised its full-year guidance.

Coca-Cola, General Motors And 3 Stocks To Watch Heading Into Tuesday

With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

inkl

Read news from The Economist, FT, and more,
with one subscription

Medpace Holdings Stock Soars After Company Tops Q2 Earnings Estimates, Raises 2025 Outlook

Medpace Holdings Stock Soars After Company Tops Q2 Earnings Estimates, Raises 2025 Outlook

Medpace Holdings Inc (NASDAQ:MEDP) shares are soaring in Monday’s after-hours session after the company reported strong financial results for the second quarter and raised its full-year guidance. Here’s what you need to know.

How execs cash in on competitors' stocks

How execs cash in on competitors' stocks

CEOs make massive bets on the stocks of direct competitors and partners — and with exquisite timing

Medpace Posts Better Than Expected Q1 Earnings, Lifts FYY22 Profit Outlook

Medpace Posts Better Than Expected Q1 Earnings, Lifts FYY22 Profit Outlook

Medpace Holdings Inc's (NASDAQ:MEDP) Q1 revenue increased 27.3% Y/Y to $330.9 million, beating the consensus of $327.09 million. On a constant currency organic basis, revenue increased 28.1%. As of March 31, 2022, the Backlog grew 28% to $2.1 billion. Net new business awards were $423 million, representing a net book-to-bill ratio of…

Medpace Reports Mixed Q4 Earnings, Issues FY22 Guidance Ahead Of Estimates

Medpace Reports Mixed Q4 Earnings, Issues FY22 Guidance Ahead Of Estimates

Medpace Holdings Inc's (NASDAQ: MEDP)

1

Organisations

Cardinal Health

Recursion Pharmaceuticals

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

380,815 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play